Related Experiment Video

Updated: Jul 7, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects

Ryoko Takasawa1, Saki Takahashi, Kazunori Saeki

  • 1Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.

Bioorganic & Medicinal Chemistry
|February 9, 2008
PubMed

Insights

Natural flavonoids can inhibit Glyoxalase I (GLO I), an enzyme overexpressed in tumors. This study identifies key flavonoid structures for developing novel anticancer drugs targeting GLO I, offering new therapeutic strategies.

Area of Science:

  • Biochemistry and Molecular Biology
  • Medicinal Chemistry
  • Cancer Research

Background:

  • Glyoxalase I (GLO I) is crucial for detoxifying methylglyoxal (MG), a glycolysis byproduct inducing apoptosis.
  • Elevated GLO I expression in tumor cells, compared to normal cells, makes it a promising anticancer drug target.
  • Specific GLO I inhibitors are sought for effective cancer therapy development.

Purpose of the Study:

  • To construct a human GLO I/inhibitor pharmacophore.
  • To identify unique human GLO I inhibitory seed compounds from natural flavonoids.
  • To guide the development of novel anticancer drugs.

Main Methods:

  • Selected natural flavonoids with specific structural features mimicking the MG transition-state.
  • Assessed inhibitory activity of flavonoids against human GLO I.
  • Analyzed structure-activity relationships (SAR) to determine key pharmacophoric elements.
  • Constructed a 3D human GLO I/inhibitor pharmacophore model.

Main Results:

  • Identified specific flavonoids exhibiting inhibitory effects on human GLO I.
  • Determined that hydroxyl groups on the B ring of flavonoids are critical for potent GLO I inhibition.
  • Established the binding mode of flavonoids to human GLO I.
  • Generated the first 3D structural data of human GLO I with flavonoid inhibitors.

Conclusions:

  • Certain flavonoids specifically interact with human GLO I.
  • The B-ring hydroxyl groups are essential for effective GLO I inhibition by flavonoids.
  • This research provides a structural basis for designing novel GLO I-targeting anticancer agents.

More Related Videos

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...